{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:17:27Z","timestamp":1792099047855,"version":"4.4.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1093\/cid\/cix125","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T08:57:10Z","timestamp":1487149030000},"page":"1275-1278","source":"Crossref","is-referenced-by-count":32,"title":["Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study"],"prefix":"10.1093","volume":"64","author":[{"given":"Charles","family":"B\u00e9guelin","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Bern University Hospital, University of Bern,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Friolet","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Bern University Hospital, University of Bern,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Moradpour","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Sahli","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, Centre Hospitalier Universitaire Vaudois, University of Lausanne,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Suter-Riniker","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases, Faculty of Medicine, University of Bern,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"L\u00fcthi","sequence":"additional","affiliation":[{"name":"Institute for Infectious Diseases, Faculty of Medicine, University of Bern,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Cavassini","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University Hospital Lausanne, University of Lausanne,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huldrych F.","family":"G\u00fcnthard","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, and"},{"name":"Institute of Medical Virology, University of Zurich,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Battegay","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases & Hospital Hygiene, University Hospital Basel,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enos","family":"Bernasconi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Regional Hospital Lugano,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Schmid","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Calmy","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University Hospital Geneva, University of Geneva, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Bern University Hospital, University of Bern,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andri","family":"Rauch","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Bern University Hospital, University of Bern,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Wandeler","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Bern University Hospital, University of Bern,"},{"name":"Institute of Social and Preventive Medicine, University of Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Swiss HIV Cohort Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,11]]},"reference":[{"key":"key\n\t\t\t\t20180328173922_CIT0001","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/cid\/ciu167","article-title":"Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients","volume":"58","author":"Fern\u00e1ndez-Montero","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328173922_CIT0002","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1086\/511867","article-title":"Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study","volume":"44","author":"Sheng","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328173922_CIT0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jmii.2013.08.001","article-title":"Higher rate of hepatitis events in patients with human immunodeficiency virus, hepatitis B, and hepatitis D genotype II infection: a cohort study in a medical center in southern Taiwan","volume":"48","author":"Lee","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"key\n\t\t\t\t20180328173922_CIT0004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jhep.2016.10.007","article-title":"Hepatitis delta-associated mortality in HIV\/HBV-coinfected patients","volume":"66","author":"B\u00e9guelin","year":"2017","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20180328173922_CIT0005","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/0168-8278(91)91716-T","article-title":"Use of alpha-interferon in the treatment of chronic delta hepatitis","volume":"13","author":"Hadziyannis","year":"1991","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20180328173922_CIT0006","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2893.2005.00601.x","article-title":"Treatment of hepatitis D","volume":"12","author":"Niro","year":"2005","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20180328173922_CIT0007","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/hep.27585","article-title":"Pegylated interferon therapy of chronic hepatitis D: in need of revision","volume":"61","author":"Rizzetto","year":"2015","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180328173922_CIT0008","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa0912696","article-title":"Peginterferon plus adefovir versus either drug alone for hepatitis delta","volume":"364","author":"Wedemeyer","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328173922_CIT0009","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2893.2007.00936.x","article-title":"Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon","volume":"15","author":"Yurdaydin","year":"2008","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20180328173922_CIT0010","volume-title":"Prolonged therapy of hepatitis delta for 96 weeks with PEG-IFNa-2a plus tenofovir or placebo does not prevent HDV RNA relapse: The HIDIT-2 Study","author":"Wedemeyer","year":"2014"},{"key":"key\n\t\t\t\t20180328173922_CIT0011","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1097\/QAD.0000000000000417","article-title":"Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients","volume":"28","author":"Soriano","year":"2014","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328173922_CIT0012","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1089\/aid.2013.0008","article-title":"Effect of tenofovir with and without interferon on hepatitis D virus replication in HIV-hepatitis B virus-hepatitis D virus-infected patients","volume":"29","author":"Boyd","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180328173922_CIT0013","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/ije\/dyp321","article-title":"Cohort profile: the Swiss HIV Cohort Study","volume":"39","author":"Schoeni-Affolter","year":"2010","journal-title":"Int J Epidemiol"},{"key":"key\n\t\t\t\t20180328173922_CIT0014","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jviromet.2011.11.001","article-title":"Quantitation of hepatitis delta virus using a single-step internally controlled real-time RT-qPCR and a full-length genomic RNA calibration standard","volume":"179","author":"Ferns","year":"2012","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20180328173922_CIT0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12879-015-1234-z","article-title":"Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study","volume":"15","author":"Hirzel","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180328173922_CIT0016","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/QAD.0b013e328352224d","article-title":"Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients","volume":"26","author":"Maylin","year":"2012","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328173922_CIT0017","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1099\/jmm.0.046649-0","article-title":"Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection?","volume":"61","author":"Babiker","year":"2012","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20180328173922_CIT0018","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.27446","article-title":"First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy","volume":"62","author":"James","year":"2015","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180328173922_CIT0019","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/QAD.0000000000000972","article-title":"Uncontrolled hepatitis delta virus infection after initial suppression on tenofovir in a HIV\/HBV-coinfected patient","volume":"30","author":"B\u00e9guelin","year":"2016","journal-title":"AIDS"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/64\/9\/1275\/13635189\/cix125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T06:51:24Z","timestamp":1522306284000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/64\/9\/1275\/2989778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,11]]},"references-count":19,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,2,11]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix125","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5,1]]},"published":{"date-parts":[[2017,2,11]]}}}